Court filings show pharmaceutical giant Johnson & Johnson has agreed to pay $7.8 million to settle a lawsuit over how the company marketed an antipsychotic drug to Arkansas doctors.
The Arkansas Democrat-Gazette reported $2 million will go to a Texas law firm that represented Arkansas in the suit, which began more than seven years ago.
A Pulaski County jury ruled three years ago that the company, through its Janssen Pharmaceutical subsidiary, committed Medicaid fraud and violated a state law in its labeling and marketing of Risperdal. A $1.2 billion fine was imposed on Johnson & Johnson, but it was later overturned by the Arkansas Supreme Court.
Janssen representative Michelle Bauer said Monday that the settlement isn’t an admission of liability.
Topics Lawsuits
Was this article valuable?
Here are more articles you may enjoy.
Chubb Outlines Structure of $20B Gulf Reinsurance Facility, Now Including Liability Cover 
US Senate Votes to Fund Most of Homeland Security After Shutdown Disrupts Airports 
Fannie Mae, Freddie Mac Will Again Accept Actual Cash Value Home Insurance 
Meta Loses Insurance for Defense in Major Social Media Addiction Litigation 
